Page 4 - நிறுவனம் ஆஃப் நுண்ணுயிரியல் சீன கலைக்கழகம் அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Junshi Biosciences Appoints Wei Qian as Chief Commerical Officer | Comunicados | Edición USA

2 jul 2021 Junshi Biosciences Appoints Wei Qian as Chief Commerical Officer SHANGHAI, China, July 02, 2021 (GLOBE NEWSWIRE) Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the company has appointed Mr. Wei Qian as Chief Commercial Officer (CCO). Mr. Qian will be responsible for the company’s commercialization planning and operations. “We are delighted to have Wei join Junshi’s senior leadership team,” said Mr. Jun Xiong, Chairman of Junshi Biosciences. “Wei has over two decades of pharmaceutical sales and marketing experience. We believe he will lead Junshi Biosciences’ commercialization to our next great milestone. By leveraging a differentiation strategy, he will advance the company to meet the unmet needs of patients in China and the world.

United statesSan franciscoWei qianJunshi bioscienceJunshi biosciencesJun xiongEli lillyInstitute of microbiology chinese academy scienceIr teamPr teamJunshi biosciences appoints wei qianChief commericalChief commercial officerVice presidentRoche chinaMicrobiology chinese academy

Investegate |Junshi Biosciences Announcements | Junshi Biosciences: Junshi Biosciences Appoints Wei Qian as Chief Commerical Officer

Junshi Biosciences Appoints Wei Qian as Chief Commerical Officer SHANGHAI, China, July 02, 2021 (GLOBE NEWSWIRE) Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the company has appointed Mr. Wei Qian as Chief Commercial Officer (CCO). Mr. Qian will be responsible for the company’s commercialization planning and operations. “We are delighted to have Wei join Junshi’s senior leadership team,” said Mr. Jun Xiong, Chairman of Junshi Biosciences. “Wei has over two decades of pharmaceutical sales and marketing experience. We believe he will lead Junshi Biosciences’ commercialization to our next great milestone. By leveraging a differentiation strategy, he will advance the company to meet the unmet needs of patients in China and the world.

United statesSan franciscoWei qianJunshi bioscienceJunshi biosciencesJun xiongEli lillyInstitute of microbiology chinese academy scienceIr teamPr teamJunshi biosciences appoints wei qianChief commericalChief commercial officerVice presidentRoche chinaMicrobiology chinese academy

Investegate |Junshi Biosciences Announcements | Junshi Biosciences: Junshi Biosciences Announces NMPA Acceptance of Investigational New Drug Application for JS014

Investegate |Junshi Biosciences Announcements | Junshi Biosciences: Junshi Biosciences Announces NMPA Acceptance of Investigational New Drug Application for JS014
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesMacau generalSan franciscoAnwita biosciencesJunshi biosciencesEli lillyInstitute of microbiology chinese academy scienceIr teamNational medical products administrationPr teamJunshi biosciences announcesInvestigational new drug applicationInvestigational new drugGreater chinaMicrobiology chinese academy

Junshi Biosciences Announces NMPA Acceptance of Investigational New Drug Application for JS014

Junshi Biosciences Announces NMPA Acceptance of Investigational New Drug Application for JS014
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesMacau generalSan franciscoAnwita biosciencesJunshi biosciencesEli lillyInstitute of microbiology chinese academy scienceIr teamNational medical products administrationPr teamInvestigational new drugGreater chinaMicrobiology chinese academyEmergency use authorizationஹாங் காங்

Junshi Biosciences Announces NMPA Acceptance of Investigational New Drug Application for JS014 | Comunicados | Edición USA

Junshi Biosciences Announces NMPA Acceptance of Investigational New Drug Application for JS014 | Comunicados | Edición USA
efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.